APA

Makboul R., Mostafa N. M., El-Deek H. E. M., Aboulhagag N. A., Shehata M. R. & Abdelhafez Y. G. (20210118). Do BRAFV600E mutation and sodium-iodide symporter expression affect the response to radioactive iodine therapy in patients with papillary thyroid carcinoma?. : Nuclear medicine communications.

Chicago

Makboul Rania, Mostafa Nadia M, El-Deek Heba E M, Aboulhagag Noha A, Shehata Mahmoud R and Abdelhafez Yasser G. 20210118. Do BRAFV600E mutation and sodium-iodide symporter expression affect the response to radioactive iodine therapy in patients with papillary thyroid carcinoma?. : Nuclear medicine communications.

Harvard

Makboul R., Mostafa N. M., El-Deek H. E. M., Aboulhagag N. A., Shehata M. R. and Abdelhafez Y. G. (20210118). Do BRAFV600E mutation and sodium-iodide symporter expression affect the response to radioactive iodine therapy in patients with papillary thyroid carcinoma?. : Nuclear medicine communications.

MLA

Makboul Rania, Mostafa Nadia M, El-Deek Heba E M, Aboulhagag Noha A, Shehata Mahmoud R and Abdelhafez Yasser G. Do BRAFV600E mutation and sodium-iodide symporter expression affect the response to radioactive iodine therapy in patients with papillary thyroid carcinoma?. : Nuclear medicine communications. 20210118.